For Old Or Young Dialysis Patients, AV Fistulas Remain Pure Gold
Main Category: Urology / NephrologyAlso Included In: Vascular; Blood / Hematology; Radiology / Nuclear Medicine
Article Date: 11 Mar 2009 - 1:00 PDT
| Patient / Public: | ![]() |
5 (2 votes) |
| Healthcare Prof: | ![]() |
A new study shows that for those individuals with chronic kidney disease, it doesn't matter if you're young or old: arteriovenous (AV) fistulas remain the gold standard for maintaining access to one's circulatory system to provide life-sustaining dialysis. Interventional radiologists found no difference between the two age groups when it comes to "patency" or the openness of AV fistulas or accesses needed for dialysis. Their results were presented at the Society of Interventional Radiology's 34th Annual Scientific Meeting.
"Elderly patients' arteriovenous (AV) fistulas - vascular accesses needed for dialysis treatment - responded just as well as those in younger patients - in length of time the access stayed open and in moving blood flow efficiently. An AV fistula is the preferred access at any age," said Andrew R. Forauer, M.D., an interventional radiologist at Dartmouth-Hitchcock Medical Center in Lebanon, N.H. When kidneys fail - called chronic kidney or end-stage renal disease - treatment in the form of regular dialysis (or hemodialysis) is needed to replace the kidney's job of ridding the body of toxic waste products to maintain fluid, electrolyte and acid-base balance. A machine is used to filter blood outside one's body, allowing blood to flow, a few ounces at a time, through a special filter that removes wastes and extra fluids. The clean blood is then returned to a dialysis patient's body. Dialysis helps women and men feel better and live longer. "One of the greatest challenges facing patients and their doctors is keeping an individual's vascular access graft open for dialysis. AV fistulas remain the gold standard of access for kidney dialysis patients. They last longer, need less rework and are associated with lower rates of infections, hospitalization and death than other types of access," explained Forauer.
A significant number of patients with chronic kidney failure receive dialysis using synthetic bridge grafts that tend to clot or malfunction, decreasing reliable access for life-sustaining dialysis and causing considerable morbidity, discomfort and inconvenience for dialysis patients, noted Forauer. "AV fistulas are underutilized in the United States yet they are best for keeping blood vessels open for access so individuals can continue to get their life-saving dialysis," said Forauer.
Researchers studied how 72 patients (36 were 75 years or older) and 36 younger patients (between the ages of 40 and 60) would fare when comparing the patency of AV fistulas. Researchers collected information about the patients' other medical conditions - such as whether they had peripheral arterial disease (PAD) or diabetes, whether they were smokers and whether they used anticoagulant medications - to see how this information would play in the big picture. Elderly patients were more likely to be affected by these conditions; however, their comparison showed no difference in primary, primary assisted, secondary or postinterventional primary patency. "AV fistula patency after intervention does not differ between younger and older patient populations," said Forauer.
Nationally, there are an estimated 27 million people with chronic kidney disease, and nearly half a million are being treated for kidney failure, requiring dialysis or kidney transplant to live. More than 340,000 individuals receive dialysis treatments three times each week, according to national statistics. Over the past five years, the number of new patients with kidney failure has averaged more than 90,000 annually. Kidneys filter waste from the blood and regulate other functions of the body.
Notes:
More information about arteriovenous (AV) fistulas, end-stage kidney disease and interventional radiology be found online at www.SIRweb.org.
Abstract 121: "Evaluation of Post-Interventional Patency of AV Fistulas in Elderly Hemodialysis Patients," M.P. Bazylewicz, Dartmouth Medical School, Hanover, N.H.; A. Forauer, Dartmouth-Hitchcock Medical Center-vascular and interventional radiology, Lebanon, NH; and K.A. Pattin, Dartmouth-Hitchcock Medical Center, Lebanon, N.H., SIR 34th Annual Scientific Meeting March 7, 2009. This abstract can be found at http://www.SIRmeeting.org.
About the Society of Interventional Radiology
Interventional radiologists are physicians who specialize in minimally invasive, targeted treatments. They offer the most in-depth knowledge of the least invasive treatments available coupled with diagnostic and clinical experience across all specialties. They use X-ray, MRI and other imaging to advance a catheter in the body, usually in an artery, to treat at the source of the disease internally. As the inventors of angioplasty and the catheter-delivered stent, which were first used in the legs to treat peripheral arterial disease, interventional radiologists pioneered minimally invasive modern medicine.
Today many conditions that once required surgery can be treated less invasively by interventional radiologists. Interventional radiology treatments offer less risk, less pain and less recovery time compared to open surgery. Visit http://www.SIRweb.org.
An estimated 5,300 people are attending the Society of Interventional Radiology's 34th Annual Scientific Meeting in San Diego.
Source: Maryann Verrillo
Society of Interventional Radiology
Visit our urology / nephrology section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/141756.php>
APA
http://www.medicalnewstoday.com/releases/141756.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




